id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-D-1334-0004,FDA,FDA-2024-D-1334,Request for Extension from Infant Nutrition Council of America (INCA),Other,Request for Extension,2025-01-24T05:00:00Z,2025,1,2025-01-24T05:00:00Z,,2025-01-24T18:58:58Z,,0,0,09000064868f1216
FDA-2024-D-1334-0002,FDA,FDA-2024-D-1334,Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula: Guidance for Industry; Draft Guidance,Other,Guidance,2024-12-04T05:00:00Z,2024,12,2024-12-04T05:00:00Z,2025-02-04T04:59:59Z,2025-02-19T02:00:38Z,,1,0,0900006486848e11
FDA-2024-D-1334-0001,FDA,FDA-2024-D-1334,Notifying the Food and Drug Administration of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request,Notice,Notice of Availability,2024-12-04T05:00:00Z,2024,12,,,2024-12-04T14:30:12Z,2024-28230,0,0,09000064868487b9